Fourpath Capital Management
BMY icon

Fourpath Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Fourpath Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$336K Hold
5,383
– – 0.04% 175
2026
Q2 		$310K Hold
5,383
– – 0.04% 188
2026
Q1 		$326K Hold
5,383
– – 0.05% 179
2025
Q4 		$290K Hold
5,383
– – 0.04% 183
2025
Q3 		$243K Sell
5,383
-575
-10% -$26.9K 0.03% 199
2025
Q2 		$276K Sell
5,958
-16,373
-73% -$804K 0.04% 194
2025
Q1 		$1.36M Sell
22,331
-2,218
-9% -$129K 0.24% 78
2024
Q4 		$1.39M Buy
24,549
+466
+2% +$26K 0.26% 78
2024
Q3 		$1.25M Buy
24,083
+8,457
+54% +$397K 0.23% 83
2024
Q2 		$649K Buy
15,626
+5,219
+50% +$234K 0.48% 50
2024
Q1 		$564K Buy
+10,407
New +$530K 0.39% 61
2022
Q4 		– Sell
-4,729
Closed -$336K – 120
2022
Q3 		$336K Sell
4,729
-4,633
-49% -$336K 0.23% 85
2022
Q2 		$721K Sell
9,362
-3,729
-28% -$284K 0.45% 52
2022
Q1 		$956K Buy
13,091
+5,556
+74% +$373K 0.38% 44
2021
Q4 		$470K Buy
+7,535
New +$442K 0.18% 97

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fourpath Capital Management's BMY Position: Q3 2026 in Review

Fourpath Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 5,383 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #175.

Fourpath Capital Management first reported a position in BMY in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.39M in Q4 2024. 623 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Fourpath Capital Management held 5,383 shares of Bristol-Myers Squibb worth $336K as of Q3 2026.
  • Fourpath Capital Management left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.04% of Fourpath Capital Management's portfolio in Q3 2026, its #175 holding.
  • Fourpath Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 15 quarters since.
  • Fourpath Capital Management's Bristol-Myers Squibb position peaked at $1.39M in Q4 2024.
  • 623 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.